Fresenius completes €524 million sale of Fresenius Medical Care shares
Fresenius sold 13.4 million Fresenius Medical Care shares at €39 each, raising approximately €524 million and reducing its stake to about 20% from 25%. Settlement is expected on November 16, 2026, and the remaining shares are subject to a 90-day lock-up.
1. Stake reduced
Fresenius completed the sale of 13,400,000 Fresenius Medical Care shares at €39 per share, raising approximately €524 million in gross proceeds. Its stake fell to approximately 20% from approximately 25%.
2. Proceeds and lock-up
Fresenius said net proceeds will be available for investment in growth platforms under its #FutureFresenius capital allocation priorities. Since deconsolidation, its holding has fallen from approximately 32%, generating cumulative gross proceeds of approximately €2.3 billion. Settlement is expected on November 16, 2026, and the remaining shares are subject to a 90-day lock-up.
